GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $888.26 million. The enterprise value is $580.22 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 62.03 million shares outstanding. The number of shares has increased by 7.70% in one year.
| Current Share Class | 62.03M |
| Shares Outstanding | 62.03M |
| Shares Change (YoY) | +7.70% |
| Shares Change (QoQ) | +6.89% |
| Owned by Insiders (%) | 31.46% |
| Owned by Institutions (%) | 34.77% |
| Float | 20.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.93 |
| P/TBV Ratio | 2.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.49, with a Debt / Equity ratio of 0.00.
| Current Ratio | 29.49 |
| Quick Ratio | 29.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.42 |
Financial Efficiency
Return on equity (ROE) is -16.35% and return on invested capital (ROIC) is -13.16%.
| Return on Equity (ROE) | -16.35% |
| Return on Assets (ROA) | -12.73% |
| Return on Invested Capital (ROIC) | -13.16% |
| Return on Capital Employed (ROCE) | -17.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$820,340 |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.91% in the last 52 weeks. The beta is 0.98, so GH Research's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +71.91% |
| 50-Day Moving Average | 13.45 |
| 200-Day Moving Average | 12.39 |
| Relative Strength Index (RSI) | 55.35 |
| Average Volume (20 Days) | 280,228 |
Short Selling Information
The latest short interest is 1.73 million, so 2.79% of the outstanding shares have been sold short.
| Short Interest | 1.73M |
| Short Previous Month | 2.27M |
| Short % of Shares Out | 2.79% |
| Short % of Float | 8.46% |
| Short Ratio (days to cover) | 5.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.99M |
| Pretax Income | -41.02M |
| Net Income | -41.02M |
| EBITDA | -52.92M |
| EBIT | -52.99M |
| Earnings Per Share (EPS) | -$0.73 |
Full Income Statement Balance Sheet
The company has $291.54 million in cash and $647,000 in debt, giving a net cash position of $308.04 million or $4.97 per share.
| Cash & Cash Equivalents | 291.54M |
| Total Debt | 647,000 |
| Net Cash | 308.04M |
| Net Cash Per Share | $4.97 |
| Equity (Book Value) | 303.18M |
| Book Value Per Share | 4.89 |
| Working Capital | 283.91M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$40.29 million and capital expenditures -$92,000, giving a free cash flow of -$40.39 million.
| Operating Cash Flow | -40.29M |
| Capital Expenditures | -92,000 |
| Free Cash Flow | -40.39M |
| FCF Per Share | -$0.65 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GH Research does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.70% |
| Shareholder Yield | -7.70% |
| Earnings Yield | -4.62% |
| FCF Yield | -4.55% |
Analyst Forecast
The average price target for GH Research is $29.33, which is 104.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.33 |
| Price Target Difference | 104.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 18.75% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |